You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 18, 2025

Profile for South Korea Patent: 101297497


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for South Korea Patent: 101297497

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Sep 28, 2031 Eli Lilly And Co VERZENIO abemaciclib
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for South Korea Patent KR101297497

Last updated: August 4, 2025


Introduction

Patent KR101297497, granted in South Korea, pertains to innovations within the pharmaceutical domain. A comprehensive understanding of this patent's scope, claims, and the broader patent landscape is vital for stakeholders involved in drug development, licensing, and intellectual property strategy. This analysis delineates the patent's scope, examines its claims, evaluates its position within the existing patent landscape, and highlights strategic considerations pertinent to the patent holder and competitors.


Patent Overview: General Context

While specific textual data from KR101297497 is limited here, typical pharmaceutical patents in South Korea follow a structured format emphasizing claims related to chemical compounds, formulations, manufacturing methods, or therapeutic indications. These patents often seek protection for novel molecules, derivatives, or implementations with specific advantages over existing therapies.

KR101297497 was likely filed to secure rights around a novel drug candidate or formulation, with claims designed to establish broad coverage of the invention's core innovative features, while also including narrower dependent claims to safeguard specific embodiments.


Scope of the Patent

1. Core Innovation Focus

The patent's primary focus is expected to be a novel chemical entity or a novel use of an existing compound with improved efficacy, safety, or manufacturing efficiency. This could involve:

  • A new molecular structure with therapeutic activity.
  • A novel formulation enhancing bioavailability.
  • A specific method of synthesis offering increased yield or purity.
  • A new therapeutic application or combination therapy.

2. Geographical and Legal Scope

The patent provides exclusive rights within South Korea, potentially extending to foreign territories if related filings exist. Its legal scope is defined through language in the claims, which detail what constitutes infringement—covering compounds, methods, or uses that fall within the scope.


Analysis of the Patent Claims

1. Independent Claims

Independent claims form the broadest protection layer, typically covering:

  • The specific chemical compound with unique structural features.
  • A method of preparing the compound.
  • A therapeutic application of the compound.

Example:
"A compound having the structure [chemical formula], or a pharmaceutically acceptable salt, hydrate, or solvate thereof."

Such claims establish the chemical's novelty and define the scope of rights to the core invention.

2. Dependent Claims

Dependent claims narrow the scope, specifying particular embodiments, such as:

  • Specific substituents on the core molecule.
  • Particular dosages or formulations.
  • Certain methods of administration.

This layered approach strengthens the patent's defensibility and provides fallback positions during litigations or licensing negotiations.

3. Claim Interpretation Considerations

The scope hinges on claim language clarity and breadth. Overly broad claims risk invalidation if prior art disclosures anticipate the invention. Conversely, narrowly drafted claims may limit enforcement. South Korean patent examination emphasizes novelty and inventive step, shaping the claims' allowable scope.


Patent Landscape Context

1. Prior Art and Novelty

The patent landscape around KR101297497 involves antecedent patents and publications related to similar chemical entities or therapeutic methods. Key considerations include:

  • Whether the compound demonstrates patentability over prior art compounds with similar structures or uses.
  • The presence of prior art disclosing similar synthesis methods or formulations.

2. Competitor Patents and Key Players

Major pharmaceutical companies and research institutions have filed numerous patents on related compounds, especially in areas like oncology, neurology, or infectious diseases where chemical innovation is critical.

3. Patent Families and International Filings

Examining related patent families through patent databases (such as KIPRIS, WIPO), reveals whether the core invention has international counterparts, impacting its strength and valuation.

4. Patent Term and Timing

Depending on filing and grant dates, KR101297497's enforceability window and competitiveness are tied to patent term extensions under Korean law. Early filing enhances exclusivity, particularly for products approaching patent expiration in prior art.


Strategic Implications

1. For Patent Holders

  • Leverage broad independent claims for enforcement.
  • File continuation or divisional applications for additional protection.
  • Monitor similar filings by competitors to prevent or challenge potential infringement or invalidity.

2. For Competitors

  • Conduct freedom-to-operate analyses to avoid infringement.
  • Identify potential design-around opportunities within the claim scope.
  • Challenge narrow or overly broad claims to weaken enforcement.

3. Licensing and Commercialization

  • Use the patent as leverage for licensing negotiations.
  • Assess the patent's coverage over the specific compounds or indications intended for commercialization.
  • Coordinate with patent portfolio strategies to maximize market exclusivity.

Concluding Remarks

Patent KR101297497 embodies a strategic asset within South Korea's pharmaceutical patent landscape. Its scope, primarily defined by carefully drafted claims, aims to secure exclusivity over a novel chemical entity or therapeutic method. Its strength depends on the breadth of independent claims and how effectively it navigates prior art. The evolving patent landscape necessitates vigilant monitoring to maintain competitive advantage, with opportunities for licensing, collaboration, or legal challenge, depending on the positioning and validity of the patent's claims.


Key Takeaways

  • Scope Worthy of Scrutiny: The patent’s broad independent claims serve as the foundation for potential market exclusivity, but must be balanced against prior art to uphold validity.
  • Claims Structure is Critical: Clear, specific dependent claims reinforce patent robustness, providing fallback options during infringement disputes.
  • Landscape Context Matters: Understanding related patents allows for strategic positioning—either to avoid infringement or to challenge weak claims.
  • Proactive IP Management: Regular monitoring and strategic patent filings (e.g., continuations, divisional applications) can extend protection lifespan.
  • Global Considerations: Patent landscapes in other jurisdictions should be investigated to maximize international market rights.

References

  1. KIPRIS Patent Database: KR101297497
  2. South Korean Patent Law: Guidelines on patent claim interpretation and patentability.
  3. Industry Reports: Trends in pharmaceutical patent filing strategies in South Korea and Asia.
  4. Patent Litigations & Case Law: Examples of claim enforcement and invalidation in South Korea.
  5. Global Patent Databases: For international patent family analysis and prior art searches.

Note: Due to limited access to the full text of KR101297497, this analysis is based on typical patent practices and public industry knowledge. For detailed infringement or validity assessments, direct review of the patent document is recommended.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.